Please use this identifier to cite or link to this item:
|Title: ||Interleukin-6 as a predictor of symptom resolution in psychological distress: a cohort study|
|Authors: ||Virtanen, Marianna|
Shipely, Martin J.
Batty, G. David
Akbaraly, Tasnime N.
Common mental disorders
|Issue Date: ||2015|
|Publisher: ||© Cambridge University Press|
|Citation: ||VIRTANEN, M. ... et al., 2015. Interleukin-6 as a predictor of symptom resolution in psychological distress: a cohort study. Psychological Medicine, 45 (10), pp 2137-2144.|
|Abstract: ||Background Elevated levels of interleukin-6 (IL-6) have been associated with the development of common mental disorders, such as depression, but its role in symptom resolution is unclear.
Method We examined the association between IL-6 and symptom resolution in a non-clinical sample of participants with psychological distress.
Results Relative to high IL-6 levels, low levels at baseline were associated with symptom resolution at follow-up [age- and sex-adjusted risk ratio (RR) = 1.15, 95% confidence interval (CI) 1.06–1.25]. Further adjustment for covariates had little effect on the association. Symptomatic participants with repeated low IL-6 were more likely to be symptom-free at follow-up compared with those with repeated high IL-6 (RR = 1.21, 95% CI 1.03–1.41). Among the symptomatic participants with elevated IL-6 at baseline, IL-6 decreased along with symptom resolution.
Conclusions IL-6 is potentially related to the mechanisms underlying recovery from symptoms of mental ill health. Further studies are needed to examine these mechanisms and to confirm the findings in relation to clinical depression.|
|Description: ||Closed access|
|Sponsor: ||The Whitehall II Study is supported by grants from the
Medical Research Council (K013351); British Heart
Foundation; National Heart Blood and Lung
Institute, National Institutes of Health (NIH), USA
(R01HL036310); and the National Institute of Aging,
NIH, USA (R01AG013196 and R01AG034454). M.V.
is supported by the Academy of Finland (258598,
265174). M.J.S. and M.H. are supported by the British
Heart Foundation. G.D.B. is a member of the
University of Edinburgh Centre for Cognitive Ageing
and Cognitive Epidemiology, part of the cross-council
Lifelong Health and Wellbeing Initiative (G0700704/
84698) and a Wellcome Trust Fellow during the
6 M. Virtanen et al.
preparation of this manuscript. K.P.E. is supported
by the Medical Research Council (G1001354), T.N.A.
by the National Heart Lung and Blood Institute
(R01HL036310) and by the Languedoc-Roussillon
Region (Chercheur d’avenir grant 2011), A.S.-M. by the
National Institute of Aging, NIH, USA (R01AG013196
and R01AG034454) and C.L.A by OHSRC/NOF/BRU/
OUCAGS. M.K. is supported by the Medical Research
Council, the NIH, USA (R01HL036310, R01AG034454)
and a professorial fellowship from the Economic and
Social Research Council.|
|Publisher Link: ||http://dx.doi.org/10.1017/S0033291715000070|
|Appears in Collections:||Closed Access (Sport, Exercise and Health Sciences)|
Files associated with this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.